当前位置:首页 - 行情中心 - 博士眼镜(300622) - 财务分析 - 利润表

博士眼镜

(300622)

  

流通市值:55.30亿  总市值:83.29亿
流通股本:1.16亿   总股本:1.75亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入915,266,819.34600,948,185.65295,927,317.031,175,865,495.37
营业收入915,266,819.34600,948,185.65295,927,317.031,175,865,495.37
二、营业总成本822,195,164.51540,825,871.28263,852,832.151,016,777,339.8
营业成本379,378,092.84251,842,867.87121,434,030.94434,226,500.56
税金及附加2,917,528.062,069,074.861,014,331.594,985,194.08
销售费用366,192,851.04239,191,021.3117,446,097.26476,163,400.24
管理费用64,089,711.1441,834,399.8921,324,543.1992,011,767.93
研发费用2,470,802.021,879,756.731,022,935.394,669,387.17
财务费用7,146,179.414,008,750.631,610,893.784,721,089.82
其中:利息费用6,841,928.014,204,821.172,010,012.927,686,666.14
其中:利息收入4,250,598.142,543,115.981,593,920.26,320,210.56
加:公允价值变动收益2,073,214.471,836,330.9-151,014.764,579,208.67
加:投资收益7,677,443.14,955,210.812,380,173.898,923,874.05
资产处置收益1,430,163.55365,012.94164,773.99875,377.38
资产减值损失(新)-3,163,640.34-2,434,492.35-1,615,299.41-9,998,872.09
信用减值损失(新)-68,837.84-929,060.07-1,578,811.42-633,090.06
其他收益2,838,042.241,897,461.511,001,324.043,896,548.75
营业利润平衡项目0000
四、营业利润103,858,040.0165,812,778.1132,275,631.21166,731,202.27
加:营业外收入233,719.299,034.6871,836.551,326,762.11
减:营业外支出1,218,519.54910,269.92407,818.473,932,531.8
利润总额平衡项目0000
五、利润总额102,873,239.6765,001,542.8731,939,649.29164,125,432.58
减:所得税费用20,074,005.7312,942,644.056,789,335.0532,370,397.57
六、净利润82,799,233.9452,058,898.8225,150,314.24131,755,035.01
持续经营净利润82,799,233.9452,058,898.8225,150,314.24131,755,035.01
归属于母公司股东的净利润83,484,416.4152,384,653.9325,035,454.54128,064,789.56
少数股东损益-685,182.47-325,755.11114,859.73,690,245.45
(一)基本每股收益0.480.30.140.74
(二)稀释每股收益0.480.30.140.74
八、其他综合收益-228,217.17479,708.581,282,810.77985,415.45
归属于母公司股东的其他综合收益-228,217.17479,708.581,282,810.77985,415.45
九、综合收益总额82,571,016.7752,538,607.426,433,125.01132,740,450.46
归属于母公司股东的综合收益总额83,256,199.2452,864,362.5126,318,265.31129,050,205.01
归属于少数股东的综合收益总额-685,182.47-325,755.11114,859.73,690,245.45
公告日期2024-10-302024-08-292024-04-262024-04-03
审计意见(境内)标准无保留意见
TOP↑